> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-227/
- Published: 2019-06-09T12:00:00.000Z
- Updated: 2026-09-15T01:31:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144299

[**Workshop on Generating Real-World Evidence**](https://www.fdaweb.com/workshop-on-generating-real-world-evidence/)  
*Federal Register* notice: FDA announces a 7/12 public workshop entitled “Leveraging Randomized Clinical Trials to Generate Real-World Evidence for Regulatory Purposes.” 06/07/2019

[**Nonalcoholic Steatohepatitis Drug Development Guide**](https://www.fdaweb.com/nonalcoholic-steatohepatitis-drug-development-guide/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment.” 06/07/2019

[**Draft Guide on Enhancing Trial Diversity**](https://www.fdaweb.com/draft-guide-on-enhancing-trial-diversity/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs.” 06/07/2019

[**Info Collection on Tobacco Product Guidance**](https://www.fdaweb.com/info-collection-on-tobacco-product-guidance/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Guidance for Industry on Establishing That a Tobacco Product Was Commercially Marketed in the United States as of 2/15/2007.” 06/04/2019

[**FDA Priority Review Voucher Used on Mayzent NDA**](https://www.fdaweb.com/fda-priority-review-voucher-used-on-mayzent-nda/)  
*Federal Register* notice: FDA permits the redemption of a priority review voucher associated with the recent approval of a Novartis NDA for Mayzent (siponimod) tablets. 06/03/2019

[**Info Collection Extension on Supplement Notifications**](https://www.fdaweb.com/info-collection-extension-on-supplement-notifications/)  
*Federal Register* notice: FDA submits to OMB an information collection extension entitled “Food Labeling; Notification Procedures for Statements on Dietary Supplements — 21 CFR 101.93.” 05/31/2019

[**Comments Sought on Opioid Unit-of-Use Packaging**](https://www.fdaweb.com/comments-sought-on-opioid-unit-of-use-packaging/)  
*Federal Register* notice: FDA seeks public comments on a potential modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy to require that certain opioid analgesics be made available in fixed-quantity unit-of-use blister packaging for outpatient dispensing. 05/31/2019